Clinical Trials Browser

Phase 2 × amivantamab × Tumor-Agnostic × Clear all

NCT05117931 2026-02-17

A Study of Amivantamab in People With Esophagogastric Cancer

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT03767075 2024-04-25

BoB

Phase 2 Recruiting

Neoplasms